Do cultures contribute to optimisation of antibiotic therapy in the intensive care unit?

International Journal of Antimicrobial Agents

Volumn 23, Issue 4, 2004, Pages 325-331

  Schurink, C A M ^a   Hoitsma, M ^a   Rozenberg Arska, M ^a   Joore, J C A ^a   Hoepelman, I M ^a   Bonten, M J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Antibiotics; Diagnosis; Infection; Intensive care unit; Therapy

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFPIROME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; FLUCLOXACILLIN; GENTAMICIN; IMIPENEM; MEROPENEM; PENICILLIN G; PIPERACILLIN; TOBRAMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; COMMUNITY ACQUIRED PNEUMONIA; DEVICE INFECTION; DIAGNOSTIC TEST; EMPIRICISM; FEMALE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; BACTERIOLOGICAL TECHNIQUES; CULTURE MEDIA; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; RESPIRATORY TRACT INFECTIONS;

EID: 1842739185     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2003.08.013     Document Type: Article

References (21)

1. Vincent J.L., Bihari D.J., Suter P.M., Bruining H.A., White J., Nicolas-Chanoin M.H.et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA. 274:1995;639-644.
2. Bergmans D.C.J.J., Bonten M.J.M., Gaillard C.A., van Tiel F.H., van der Geest S., de Leeuw P.W.et al. Indications for antibiotic use in ICU patients: a one-year prospective surveillance. J. Antimicrob. Chemother. 39:1997;527-535.
3. Levy S.B. Multidrug resistance. A sign of the times. New Engl. J. Med. 338:1998;1376-1378.
4. Winer-Muram H.T., Rubin S.A., Miniati M., Ellis J.V. Guidelines for reading and interpreting chest radiographs in patients receiving mechanical ventilation. Chest. 102:1992;565S-570S.
5. O'Grady N.P., Barie P.S., Bartlett J.G., Bleck T., Garvey G., Jacobi J.et al. Practice guidelines for evaluating new fever in critically ill adult patients. Clin. Infect. Dis. 26:1998;1042-1059.
6. American Thoracic Society. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, November 1995. Am J Respir Crit Care Med 1996;153:1711-25.
7. A'Court C., Garrard C.S. Nosocomial pneumonia in the intensive care unit: mechanisms and significance. Thorax. 47:1992;465-473.
8. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., Hughes J.M. CDC definitions for nosocomial infections, 1988. Am. J. Infect. Control. 16:1988;128-140.
9. Pugin J., Auckenthaler R., Mili N., Janssens J.P., Lew P.D., Suter P.M. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic 'blind' bronchoalveolar lavage fluid. Am. Rev. Respir. Dis. 143:1991;1121-1129.
10. American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia. Am J Respir Crit Care Med 2001;163:1730-54.
11. Chastre J., Fagon J.Y., Domart Y., Gibert C. Diagnosis of nosocomial pneumonia in intensive care unit patients. Eur. J. Clin. Microbiol. Infect. Dis. 8:1989;35-39.
12. National Commitee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Eleventh informational supplement. Wayne, PA: NCCLS, 2001 [Document 100-S11].
13. Alvarez-Lerma F. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group. Intensive Care Med. 22:1996;387-394.
14. Rello J., Gallego M., Mariscal D., Sonora R., Valles J. The value of routine microbial investigation in ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med. 156:1997;196-200.
15. Kollef M.H., Ward S. The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest. 113:1998;412-420.
16. Bonten M.J., Bergmans D.C., Stobberingh E.E., van der Geest S., De Leeuw P.W., van Tiel F.H.et al. Implementation of bronchoscopic techniques in the diagnosis of ventilator-associated pneumonia to reduce antibiotic use. Am. J. Respir. Crit. Care Med. 156:1997;1820-1824.
17. Hayon J., Figliolini C., Combes A., Trouillet J.L., Kassis N., Dombret M.C.et al. Role of serial routine microbiologic culture results in the initial management of ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med. 165:2002;41-46.
18. Fagon J.Y., Chastre J., Wolff M., Gervais C., Parer-Aubas S., Stephan F.et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann. Intern. Med. 132:2000;621-630.
19. Niederman M.S., Torres A., Summer W. Invasive diagnostic testing is not needed routinely to manage suspected ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med. 150:1994;565-569.
20. Hoffken G., Niederman M.S. Nosocomial Pneumonia: The importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU. Chest. 122:2002;2183-2196.
21. Ibrahim E.H., Ward S., Sherman G., Schaiff R., Fraser V.J., Kollef M.H. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit. Care Med. 29:2001;1109-1115.